297 related articles for article (PubMed ID: 18651631)
1. Targeting the folate receptor (FR): imaging and cytotoxicity of ReI conjugates in FR-overexpressing cancer cells.
Viola-Villegas N; Rabideau AE; Cesnavicious J; Zubieta J; Doyle RP
ChemMedChem; 2008 Sep; 3(9):1387-94. PubMed ID: 18651631
[TBL] [Abstract][Full Text] [Related]
2. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
3. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
Reddy JA; Westrick E; Santhapuram HK; Howard SJ; Miller ML; Vetzel M; Vlahov I; Chari RV; Goldmacher VS; Leamon CP
Cancer Res; 2007 Jul; 67(13):6376-82. PubMed ID: 17616697
[TBL] [Abstract][Full Text] [Related]
5. Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates.
Canal F; Vicent MJ; Pasut G; Schiavon O
J Control Release; 2010 Sep; 146(3):388-99. PubMed ID: 20621587
[TBL] [Abstract][Full Text] [Related]
6. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
[TBL] [Abstract][Full Text] [Related]
8. Pyrophosphate-bridged complexes with picomolar toxicity.
Ikotun OF; Higbee EM; Ouellette W; Doyle RP
J Inorg Biochem; 2009 Sep; 103(9):1254-64. PubMed ID: 19666193
[TBL] [Abstract][Full Text] [Related]
9. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
10. Folate-PEG modified poly(2-(2-aminoethoxy)ethoxy)phosphazene/DNA nanoparticles for gene delivery: synthesis, preparation and in vitro transfection efficiency.
Zhang P; Zhang Z; Yang Y; Li Y
Int J Pharm; 2010 Jun; 392(1-2):241-8. PubMed ID: 20298769
[TBL] [Abstract][Full Text] [Related]
11. Targeting the cubilin receptor through the vitamin B(12) uptake pathway: cytotoxicity and mechanistic insight through fluorescent Re(I) delivery.
Viola-Villegas N; Rabideau AE; Bartholomä M; Zubieta J; Doyle RP
J Med Chem; 2009 Aug; 52(16):5253-61. PubMed ID: 19627091
[TBL] [Abstract][Full Text] [Related]
12. Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.
Marverti G; Cusumano M; Ligabue A; Di Pietro ML; Vainiglia PA; Ferrari A; Bergomi M; Moruzzi MS; Frassineti C
J Inorg Biochem; 2008 Apr; 102(4):699-712. PubMed ID: 18082268
[TBL] [Abstract][Full Text] [Related]
13. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
[TBL] [Abstract][Full Text] [Related]
14. Folate-conjugated micelles and their folate-receptor-mediated endocytosis.
Lu T; Sun J; Chen X; Zhang P; Jing X
Macromol Biosci; 2009 Nov; 9(11):1059-68. PubMed ID: 19688723
[TBL] [Abstract][Full Text] [Related]
15. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
16. [Folate receptor-mediated antitumor drugs].
Zhao J; Cao SL; Zheng XL; Zhao B
Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
[TBL] [Abstract][Full Text] [Related]
17. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity of a folate peptide camptothecin prodrug.
Henne WA; Doorneweerd DD; Hilgenbrink AR; Kularatne SA; Low PS
Bioorg Med Chem Lett; 2006 Oct; 16(20):5350-5. PubMed ID: 16901694
[TBL] [Abstract][Full Text] [Related]
20. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
Gay M; Montaña AM; Moreno V; Prieto MJ; Pérez JM; Alonso C
Bioorg Med Chem; 2006 Mar; 14(5):1565-72. PubMed ID: 16256352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]